Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.

<h4>Background</h4>Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profi...

Full description

Bibliographic Details
Main Authors: Akash Malhotra, Ryan Thompson, Margaretha De Vos, Anura David, Samuel Schumacher, Hojoon Sohn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0290496